This topic contains a solution. Click here to go to the answer

Author Question: A patient being ventilated with APRV has the following settings: Phigh = 24 cm H2O; Thigh = 5 sec; ... (Read 40 times)

dalyningkenk

  • Hero Member
  • *****
  • Posts: 598
A patient being ventilated with APRV has the following settings: Phigh = 24 cm H2O; Thigh = 5 sec; Plow = 4 cm H2O; Tlow = 1 second, FIO2 = 0.3.
 
  The patient's spontaneous respiratory rate is 10 breaths/min. The current arterial blood gas values are: PaO2 = 91 mm Hg; PaCO2 = 62 mm Hg. What should the respiratory therapist recommend for this patient?
  a. Increase the Plow to 5.5 cm H2O.
  b. Decrease the Tlow to 0.5 sec.
  c. Increase the Phigh to 40 cm H2O.
  d. Decrease the Plow to 0 cm H2O.

Question 2

Which variable in APRV is responsible for the removal of CO2 from the body?
 
  a. Tlow
  b. Thigh
  c. Plow
  d. Phigh



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

bd5255

  • Sr. Member
  • ****
  • Posts: 386
Answer to Question 1

ANS: D
To decrease the PaCO2, the Phigh/Plow gradient needs to be increased without increasing the Phigh above 35 cm H2O. Decreasing the Plow to 0 cm H2O is one way to increase that gradient. Increas-ing the Plow would decrease the gradient and therefore the VT. Although raising the Phigh would increase the pressure gradient and therefore the VT, pressures above 35 cm H2O increase the risk of overdistention injury.

Answer to Question 2

ANS: A
During the release time, or Tlow, the patient exhales a volume of gas; this allows ventilation and the removal of CO2 from the body.




dalyningkenk

  • Member
  • Posts: 598
Reply 2 on: Jul 16, 2018
Wow, this really help


anyusername12131

  • Member
  • Posts: 327
Reply 3 on: Yesterday
Thanks for the timely response, appreciate it

 

Did you know?

Colchicine is a highly poisonous alkaloid originally extracted from a type of saffron plant that is used mainly to treat gout.

Did you know?

For high blood pressure (hypertension), a new class of drug, called a vasopeptidase blocker (inhibitor), has been developed. It decreases blood pressure by simultaneously dilating the peripheral arteries and increasing the body's loss of salt.

Did you know?

Women are 50% to 75% more likely than men to experience an adverse drug reaction.

Did you know?

In the United States, an estimated 50 million unnecessary antibiotics are prescribed for viral respiratory infections.

Did you know?

This year, an estimated 1.4 million Americans will have a new or recurrent heart attack.

For a complete list of videos, visit our video library